Helix puts anti-wrinkle treatment on the market

Related tags Cosmetics

US biotechnology company Helix BioMedix has entered a strategic
venture with Body Blue to market its proprietary peptides for use
in a number of products such as anti-wrinkle lotions, anti-acne
gels, deodorants and mouthwashes. The move aims to tap into the
growing market for peptides in cosmetics due to their non-allergic
properties.

The agreement, which also gives Body Blue the opportunity to formulate and manufacture consumer products using the bioactive peptides, should help to develop the use of the ingredient in the all-important North American market, with the potential for it to break into other international markets at a later stage.

Helix BioMedix​ CEO, R. Stephen Beatty, said of the agreement with Body Blue. "They have built an impressive track record of delivering consumer products to the marketplace quickly. We believe that they have the potential of dramatically accelerating our time-to-market for many important, high-value products containing Helix BioMedix peptides. In addition, they provide us with significant expertise in formulation and manufacturing."

Canada-based Body Blue is a contract formulator and manufacturer of topical personal care and cosmetic products. Employing over 300 staff it produces, it produces a wide range of products for a number of leading cosmetic retailers in the industry using patented agreements for ingredients such as the one just struck up with Helix BioMedix. Currently it is working with companies such as Revlon, P&G and Avalon Organics and recently doubled the size of its manufacturing facility in Ontario.

As consumers become more and more demanding with regards the functionality of cosmetics, the formulation of cosmetics ingredients is, likewise, becoming increasingly complex. As well as non-allergic properties, peptides are known to be a safe active ingredient that blends well with other ingredients without causing undesirable reactions.

"Our major customers are demanding more premium products with safe and effective proprietary ingredients that cannot be copied,"​ said David Elliot, president of Body Blue. "Our partnership with Helix BioMedix gives us access to a virtually unlimited number of actives to fill this growing market need."

Currently discussions are under way with a number of Body Blue's clients to target the ingredient in a number of cosmetics products.

Related topics Formulation & Science Skin Care

Related news

Related products

show more

Get up to $500 off IGEN™ Non-GMO Tested Program!

Get up to $500 off IGEN™ Non-GMO Tested Program!

Content provided by SGS Nutrasource | 04-Jul-2024 | Insight Guide

The cosmetics industry has seen unprecedented growth in recent years, and with this growth comes a rising concern for what’s inside our everyday products.

Calendula Cellular Elixir: Alchemy in a cell

Calendula Cellular Elixir: Alchemy in a cell

Content provided by Naolys | 07-Jun-2024 | Product Brochure

Get ready to experience a cellular evolution in skincare with InnerLift Calendula's advanced Plant Cell biotechnology.

Exosomes: Passing Trend or Transformative Reality?

Exosomes: Passing Trend or Transformative Reality?

Content provided by Naolys | 26-Mar-2024 | White Paper

Exosomes, microscopic vesicles naturally present in abundance within Plant Cells, have garnered significant attention within the scientific and cosmetic...

Related suppliers

Follow us

Products

View more

Webinars